Introduction
Vagus nerve stimulation (VNS) is a relatively new therapeutic option for patients with refractory epilepsy. 4 The mode of action is complex, the afferents of the vagus nerve first reach the nucleus tractus solitarii which in turn has multiple connections to many other regions of the brain. Topically differentiated changes of the EEG, 6 ,8 the cerebral perfusion, 5 activation patterns as studied by functional magnetic resonance imaging are induced.
Most studies on the influence of VNS on cardiac regulation and heart rate variability did not find systematic effect of VNS 3 but patients with asystolia during the implantation have been described, 7 and there may be a positive effect on the incidence of SUDEP (sudden unexpected death in epilepsy) in patients treated with VNS. 1, 2 We report a patient who is interesting in two aspects: to the best of our knowledge, no patient with epilepsy and such a severe impairment of HRV has been reported in the past. Second, we could demonstrate in our patient that HRV was improved by VNS.
Case report
JS was born as a preterm of 31 weeks to healthy nonrelated Caucasian parents, because of premature rupture of membranes.
Seizures began at 3 months of age and were either tonic or myoclonic in the beginning, occurring every few days at onset. The EEG showed focal Seizure (2008) seizure activity located at the right frontal brain. In the years afterwards most EEGs showed only a diffuse slowing but no seizure activity. Treatment was begun with phenobarbitone, carbamazepine was added with a limited success for the next 6 months. Seizures reoccurred at 14 months of age, now as hemi-grand mal of the right side, at 17 months complex partial seizures were also seen. Hemi tonic or tonic-clonic seizures were noted several times per week during the night. At 20 months of age, atonic drop attacks several times a day became prominent, and the diagnosis of Lennox-Gastaut-Syndrome was made.
Extensive metabolic and genetic testing did not yield any pathological finding; repeated MRI scans revealed a slight diffuse atrophy of the brain and no focal pathology. The psychomotor development was delayed, but the girl has learned to talk normally, has impaired fine motor skills, impaired coordination but good social skills, allowing her an overall acceptable quality of life today at 15 years of age.
The seizures proved to be refractory to all old and new antiepileptic drugs, with a certain effect of valproate on the generalized seizures and of felbamate on facial myoclonic seizures. Nevertheless, the girl continued to have several seizures every day, now prolonged atonic, shorter tonic-clonic and occasional complex-partial seizures.
Intravenous steroids also had only a partial and transient effect the first time with a reduction of the seizure frequency of about 50% and much less effect when applied the second time.
With oxcarbazepine hyponatremia occurred but did not recover after stopping the drug. A permanent fludrocortisone substitution now keeps the sodium level stable.
At 8 years and 6 months of age, a vagus nerve stimulator (VNS) was implanted, with several positive effects.
A cardiologic check-up in advance including a echocardiography and an ECG did not show any pathologies.
Tonic-clonic seizures can be stopped very well by additional vagus nerve stimulation when applied immediately after the onset of seizures. This has dramatically decreased the use of additional benzodiazepines, so the patient had been able to attend her special school again regularly, which had not been the case for years before. Also, the wakefulness, the initiative and interest improved very much--and deteriorated markedly before the battery was exchanged 2 years ago, returning to the positive level with the new stimulator. Even though prolonged atonic seizures and drop attacks continue to occur every day, the quality of life had improved impressively with VNS.
The girl has had problems with occasional syncopes, sometimes with prolonged episodes of low blood pressure below 80/40 mmHg for up to a day, together with paleness, dizziness and a decreased level of activity. It was not possible to clarify the exact cause of the syncopes, assumedly the girl showed a dysregulation of the vessels tone, any cardiac arrhythmia could not be found. Additionally the large amount of the used benzodiazepines was supposed to be a supporting cause to trigger syncopes.
Heart rate variability (HRV)
HRV refers to the beat-to-beat alterations in heart rate. The ECG of healthy individuals exhibits periodic variation in RR-intervals. This rhythmic phenomenon, known as respiratory sinus arrhythmia (RSA), fluctuates with the phase of respiration, cardio-acceleration during inspiration, and cardiodeceleration during expiration. RSA is predominantly mediated by parasymphathetic efferent activity to the heart: vagal efferent traffic to the sinus node occurs primarily in phase with expiration and is absent or attenuated during inspiration. Reduced HRV has thus been used as a marker of a dysfunction in autonomic nerveous system.
The HF-band is related to the parasympathic system, the LF-band to the sympathic system. The ratio of the power contained in the LF and HF components has been used as a measure of the sympathovagal balance. Reduced HRV is a strong predictor of mortality in myocardial infarction and heart failure, indeed a very rigid and inflexible HRV is related to severe dysfunctions of the ANS (autonomic nervous system). Figure 1 Heart frequency and the RR-intervals at rest. Fig. 1 shows the heart frequency and the RRintervals at rest in a lying position, with the VNS turned off. There is almost no variability of the heart frequency, which is also quite impressing in Table 1 : the mean RR-interval was 722 ms, the standard deviation being 16.04 ms and the variation coefficient 2. 2 /s. Interestingly, the power increased impressively as the VNS was turned on again (stimulation parameters: output current 3,00 mA, signal frequency 20 Hz, pulse with 500 ms, signal on 30 s, signal off 1.8 min, magnet current 3.25 mA, magnet pulse with 500 ms). With this stimulation, the power in the LF rose to 641.7 ms 2 /s, in the MF to 147.6 ms 2 /s, and in the HF band to 61.81 ms 2 /s ( Table 2 ). The improved HRV and the increased power is depicted in Fig. 2 . This is still clearly pathological as compared to a healthy control child (Table 3 ) but the increase in HRV and power is dramatic nevertheless as it is usually the case in other patients.
Discussion
Our patient is of interest in two aspects with view to the ANS: the impairment of HRV is extreme, with virtually no HRV left at all. Such findings can usually be obtained only in critically ill patients, especially in decerebrated individuals. In a child without any other cause of an autonomic neuropathy who leads an almost normal life this impairment is most unusual. Second, we demonstrated a drastic increase of HRV with VNS. VNS afferents reach many different regions of the brain, as the Nucleus tractus solitarii is the first target of vagus afferents.
The cause of this impairment is not quite clear. It may be due to the severe epilepsy, to the antiepileptic drugs, or HRV may not have been normal even before the onset of seizures. Neither related to epilepsy itself nor to antiepileptic drugs such a poor HRV have been described before. We believe that neither changes of respiration nor of thermoregulation-related changes nor of the baroreceptor-reflex can explain the reduction of HRV. We believe that our patient has several pecularities (e.g. her prematurity or her Lennox-Gastaut-Syndrome) that make the girl rather unique as a patient. The autonomic impairment may be considered a regulatory defect not directly related to the other problems. This severe impairment, however, may allow observing effects of VNS not visible in patients without this problem. Figure 2 Heart frequency (HF) with VNS turned on. 
